Navigation Links
InfuSystem Holdings Reports 14.5% Revenue Increase and Approximately $3.6 Million of Adjusted EBITDA for the Third Quarter of 2008
Date:11/5/2008

(0.02) N/A

Adj. EBITDA EPS - diluted 0.19 (0.02) N/A

Reconciliation from Net Income to Adjusted EBITDA:

(in thousands, except per share data)

Nine Months Ended September 30

I-Flow Predecessor

2008 2007 2007

Net Income $8,700 $(928) $3,604

Adjustments:

Interest expense 2,828 33 (237)

Interest income (14) (3,534) -

Income tax expense 399 752 2,460

Depreciation -- Pumps 2,908 - 2,307

Depreciation -- Other 133 - 125

Amortization 1,370 - -

EBITDA $16,325 $(3,677) $8,259

Adjustments:

(Gain) loss on derivatives (8,665) 675 -

Stock based compensation 1,166 1,490 305

Adj. EBITDA $8,826 $(1,512) $8,564

Adj. EBITDA EPS - basic 0.50 (0.08) N/A

Adj. EBITDA EPS - diluted 0.47 (0.08) N/A

About InfuSystem Holdings, Inc.

InfuSystem is the leading provider of ambulatory infusion pumps and associated clinical services for oncology practices and their patients in the U.S. These pumps allow for the gradual delivery of a drug over a period of days in the privacy of one's home, compared to bolus infusion chemotherapy treatments that are given in a single high dose over a short period of time. Improved efficacy of the drugs, patient comfort, reimbursement to doctors for appropriate services and continuity of care all play a role in the grow
'/>"/>

SOURCE InfuSystem Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. InfuSystem Holdings Provides Business Update and Comments on Fourth Quarter 2007 Financial Results
2. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
3. BioAuthorize Holdings, Inc. Names New Directors and Executive and Unveils Modification to Its Voice Biometric Authentication Service
4. China Pharma Holdings, Inc. Appoints The Ruth Group
5. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
6. China Bio Energy Holdings Group Announces Financing and Exercise of Warrants
7. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2008 Results
8. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
9. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
10. China Bio Energy Holdings Group Announces Participation in the Susquehanna Second Annual Beijing Management Summit
11. China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) Beijing Management Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Selexis SA, a ... Research Cell Banks (RCBs) used for drug discovery to ... Banks will include Next-Generation Sequencing (NGS) data ... de-risks biologic manufacturing by ensuring the integrity of the ...
(Date:1/22/2015)... 22, 2015   Cypher Genomics, Inc., the ... SQNM ), the leading molecular diagnostics ... generation noninvasive prenatal tests (NIPT). Through this agreement, ... Mantis™, to advance analysis of clinically-relevant fetal sub-chromosomal ...
(Date:1/22/2015)... 22, 2015  Derma Sciences, Inc. (Nasdaq: ... advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, ... added to the Premier, Inc. Regenerative Skin Grafting ... the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue ...
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 PlasmaTech ... care in critical areas, announced the closing of an underwritten ... to purchase up to an aggregate 3,500,000 shares of common ... $.01 per warrant.  The warrants have a per share exercise ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... , SOUTHAMPTON, Pa., June 23 Environmental Tectonics Corporation ... announced that their BioMedical Division will be exhibiting at ... UHMS is an international, non-profit organization and is the ... medicine physiology worldwide. , , The 2009 Annual ...
... Will Be Used For NDA and to Complete Current ... , , BETHESDA, Md., June 23 Spherix ... biotechnology for diabetes therapy, and a provider of technical ... pharmaceutical companies, today announced that it has received its ...
... June 23 Advanced Life Sciences Holdings, Inc. (OTC ... primate study involving its novel, once-a-day, oral antibiotic Restanza(TM) ... a 100% survival rate against an inhaled lethal dose ... that received 16 mg/kg once-a-day (the human equivalent dose ...
Cached Biology Technology:Environmental Tectonics Corporation's BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting 2Environmental Tectonics Corporation's BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting 3Environmental Tectonics Corporation's BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting 4Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 2Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 3Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 4Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study 2Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study 3
(Date:12/22/2014)... (NASDAQ: NXTD and NXTDW) ("NXT-ID" or the ... commerce market, announces it has retained famous pickpocket, entertainer and ... CES debut of the Wocket™ biometric smart wallet.  ... booth January 6th and 7 th , 2015, demonstrating some ...
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced the ... Security Systems Market" report to their offering. ... perimeter security market is estimated to grow at a CAGR ... holds a larger share in this market, Canada ...
(Date:12/17/2014)... Dec. 15, 2014 The Defense Logistics Agency is ... and prevent counterfeit microcircuits from entering into its supply ... in-house microcircuit anti-counterfeit initiative dubbed DNA marking. The capability ... their reliability throughout the supply chain. The new quality ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... four times more likely to develop the debilitating disorder ... findings in a new paper Incidence of unilateral arm ... published in the prestigious journal The Lancet Oncology ... cancer increases the risk of developing arm lymphoedema. ...
... now publishing the Journal of Control, Automation and Electrical ... Society for Automatics (SBA). Formerly known as Controle and ... year, and all articles will be available on Springer,s online ... Control, Automation and Electrical Systems covers industrial automation, addressing ...
... are well known for their hallucinogenic properties. Until now, ... how they should be classified in the fungal Tree ... of a fascinating fungi that has wide recreational use ... medicinal applications. In the 19th century, the ...
Cached Biology News:Breast cancer surgery linked to swollen arm syndrome 2Journal of Control, Automation and Electrical Systems now published by Springer 2Family matters: Evolutionary relationships among species of 'magic' mushrooms shed light on fungi 2
Rabbit polyclonal to Kallikrein 1 ( Abpromise for all tested applications). Antigen: Full length native kallikrein from tissue (Human) Entrez Gene ID: 3816 Swiss Protein ID: P06870...
PSGL-1 (215)...
Mouse Anti-human CD11b/Mac-1alpha, clone LM2/1, Monoclonal Antibody...
Mouse monoclonal [MLM544] to cardiac Myosin light chain 1 ( Abpromise for all tested applications). entrezGeneID: 4634 SwissProtID: P08590...
Biology Products: